Clinical Trials
6 trialsNCT00750841 2026-05-19
Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours
AstraZeneca
Phase 1 Active not recruiting
NCT00621725 2014-07-15
Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours
AstraZeneca
Phase 1 Completed
NCT00306891 2012-11-01
Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentinâ„¢)
AstraZeneca
Phase 2 Completed
NCT00748891 2011-07-01
DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study)
AstraZeneca
Phase 1 Completed
NCT00750425 2011-03-10
Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours
AstraZeneca
Phase 1 Completed
NCT00503412 2009-01-19
Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors
AstraZeneca
Phase 1 Completed